NewsRx

Search our medical news database

Immunotherapy

Tumor Regression and Rechallenge Immunity with Adenoviral Gene Transfer

Published in Cancer Weekly, September 25th, 1995

Highly effective cancer immunotherapies are possible using adenoviral vectors expressing cytokines.

Research has shown that cancers often lack the secondary costimulatory signals required to produce the cytokines necessary to stimulate the host's immune system against the tumor. Adding exogenous cytokines has produced some successes toward overcoming the anergy of the host immune effector cells.

Christina L. Addison et al. sought an effective method of achieving high concentrations of the cytokine IL-2 by using an adenoviral gene delivery system to express IL-2 continuously around and within the tumor ("Intratumoral Injection of an Adenovirus...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook